177 related articles for article (PubMed ID: 18026163)
1. The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1.
Butler SL; Dong H; Cardona D; Jia M; Zheng R; Zhu H; Crawford JM; Liu C
Lab Invest; 2008 Jan; 88(1):78-88. PubMed ID: 18026163
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma.
Liu H; Dong H; Robertson K; Liu C
Am J Pathol; 2011 Feb; 178(2):652-61. PubMed ID: 21281797
[TBL] [Abstract][Full Text] [Related]
3. Loss of Hep Par 1 immunoreactivity in the livers of patients with carbamoyl phosphate synthetase 1 deficiency.
Yamaguchi M; Kataoka TR; Shibayama T; Fukuda A; Nakazawa A; Minamiguchi S; Sakurai T; Miyagawa-Hayashino A; Yorifuji T; Kasahara M; Uemoto S; Haga H
Pathol Int; 2016 Jun; 66(6):333-6. PubMed ID: 27150549
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating tumor cells in hepatocellular carcinoma using antibodies against asialoglycoprotein receptor, carbamoyl phosphate synthetase 1 and pan-cytokeratin.
Li J; Chen L; Zhang X; Zhang Y; Liu H; Sun B; Zhao L; Ge N; Qian H; Yang Y; Wu M; Yin Z
PLoS One; 2014; 9(4):e96185. PubMed ID: 24763545
[TBL] [Abstract][Full Text] [Related]
5. The activity of the carbamoyl phosphate synthase 1 promoter in human liver-derived cells is dependent on hepatocyte nuclear factor 3-beta.
Chen Z; Tang N; Wang X; Chen Y
J Cell Mol Med; 2017 Sep; 21(9):2036-2045. PubMed ID: 28272778
[TBL] [Abstract][Full Text] [Related]
6. Improved method increases sensitivity for circulating hepatocellular carcinoma cells.
Liu HY; Qian HH; Zhang XF; Li J; Yang X; Sun B; Ma JY; Chen L; Yin ZF
World J Gastroenterol; 2015 Mar; 21(10):2918-25. PubMed ID: 25780289
[TBL] [Abstract][Full Text] [Related]
7. Generation of carbamoyl phosphate synthetase 1 reporter cell lines for the assessment of ammonia metabolism.
Wang Y; Chang L; Zhai J; Wu Q; Wang D; Wang Y
J Cell Mol Med; 2017 Dec; 21(12):3214-3223. PubMed ID: 28557353
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of Carbamoyl Phosphate Synthetase 1 Engenders Radioresistance in Hepatocellular Carcinoma via Deubiquitinating c-Myc.
Zhang S; Hu Y; Wu Z; Zhou X; Wu T; Li P; Lian Q; Xu S; Gu J; Chen L; Wu G; Zhang T; Tang J; Xue J
Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1244-1256. PubMed ID: 36423742
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a Carbamoyl Phosphate Synthetase 1-Deficient HCC Subtype With Therapeutic Potential Through Integrative Genomic and Experimental Analysis.
Wu T; Luo G; Lian Q; Sui C; Tang J; Zhu Y; Zheng B; Li Z; Zhang Y; Zhang Y; Bao J; Hu J; Shen S; Yang Z; Wu J; Wang K; Zhao Y; Yang S; Wang S; Qiu X; Wang W; Wu X; Wang H; Gu J; Chen L
Hepatology; 2021 Dec; 74(6):3249-3268. PubMed ID: 34343359
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract.
Maitra A; Murakata LA; Albores-Saavedra J
Am J Clin Pathol; 2001 May; 115(5):689-94. PubMed ID: 11345832
[TBL] [Abstract][Full Text] [Related]
11. Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
Laemmle A; Hahn D; Hu L; Rüfenacht V; Gautschi M; Leibundgut K; Nuoffer JM; Häberle J
Mol Genet Metab; 2015 Mar; 114(3):438-44. PubMed ID: 25639153
[TBL] [Abstract][Full Text] [Related]
12. Loss of carbamoyl phosphate synthetase I in small-intestinal adenocarcinoma.
Cardona DM; Zhang X; Liu C
Am J Clin Pathol; 2009 Dec; 132(6):877-82. PubMed ID: 19926579
[TBL] [Abstract][Full Text] [Related]
13. Y-box binding protein-1 down-regulates expression of carbamoyl phosphate synthetase-I by suppressing CCAAT enhancer-binding protein-alpha function in mice.
Chen YR; Sekine K; Nakamura K; Yanai H; Tanaka M; Miyajima A
Gastroenterology; 2009 Jul; 137(1):330-40. PubMed ID: 19272383
[TBL] [Abstract][Full Text] [Related]
14. Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapy.
Khoja S; Nitzahn M; Hermann K; Truong B; Borzone R; Willis B; Rudd M; Palmer DJ; Ng P; Brunetti-Pierri N; Lipshutz GS
Mol Genet Metab; 2018 Aug; 124(4):243-253. PubMed ID: 29801986
[TBL] [Abstract][Full Text] [Related]
15. Unraveling the therapeutic potential of carbamoyl phosphate synthetase 1 (CPS1) in human diseases.
Zhang L; Zou Y; Lu Y; Li Z; Gao F
Bioorg Chem; 2023 Jan; 130():106253. PubMed ID: 36356370
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte Antigen Expression in Barrett Esophagus and Associated Neoplasia.
Shah SS; Chandan VS
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):557-561. PubMed ID: 28187035
[TBL] [Abstract][Full Text] [Related]
17. Protein tyrosine nitration of mitochondrial carbamoyl phosphate synthetase 1 and its functional consequences.
Takakusa H; Mohar I; Kavanagh TJ; Kelly EJ; Kaspera R; Nelson SD
Biochem Biophys Res Commun; 2012 Mar; 420(1):54-60. PubMed ID: 22402285
[TBL] [Abstract][Full Text] [Related]
18. Purification of carbamoyl phosphate synthetase 1 (CPS1) from wood frog (Rana sylvatica) liver and its regulation in response to ice-nucleation and subsequent whole-body freezing.
Green SR; Storey KB
Mol Cell Biochem; 2019 May; 455(1-2):29-39. PubMed ID: 30421312
[TBL] [Abstract][Full Text] [Related]
19. Studies on the biological functions of CPS1 in AFB1 induced hepatocarcinogenesis.
Yang C; Fu R; Zhuang Z; Wang S
Gene; 2016 Oct; 591(1):255-261. PubMed ID: 27425868
[TBL] [Abstract][Full Text] [Related]
20. The Study of Carbamoyl Phosphate Synthetase 1 Deficiency Sheds Light on the Mechanism for Switching On/Off the Urea Cycle.
Díez-Fernández C; Gallego J; Häberle J; Cervera J; Rubio V
J Genet Genomics; 2015 May; 42(5):249-60. PubMed ID: 26059772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
